Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year ...
PRAX-114 Phase 2/3 monotherapy MDD Aria Study topline results expected in June 2022
Source: kentuckynewera.com
Stay updated with breaking news from Maria Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PRAX-114 Phase 2/3 monotherapy MDD Aria Study topline results expected in June 2022